https://www.cidrap.umn.edu/news-perspective/2022/11/ebola-sickens-another-ugandan-health-worker
Ebola sickens another Ugandan health worker
Filed Under:
Ebola;
Viral Hemorrhagic Fever
Uganda has reported one more lab-confirmed Ebola infection, which involves a 23-year-old woman who is a healthcare worker in Mubende, one of the outbreak's hot spots, according to an update yesterday from the World Health Organization (WHO) Uganda office.
Her illness lifts Uganda's Ebola total to 140 cases and the number of infected health workers to 19, including 7 who died from their infections.
No new deaths were reported, keeping fatalities at 55. The case-fatality rate among the confirmed cases is 39%. Uganda has also reported at least 21 suspected cases, mostly from earlier in the outbreak, all of which were fatal.
Uganda's outbreak began in September and involves the more rare Sudan Ebola strain. Unlike the more common Zaire Ebola strain, there are no approved treatments or vaccines. Officials have said a small number of patients have received experimental treatments, and plans are under way to test as three vaccine candidates.
Ebola sickens another Ugandan health worker
Filed Under:
Ebola;
Viral Hemorrhagic Fever
Uganda has reported one more lab-confirmed Ebola infection, which involves a 23-year-old woman who is a healthcare worker in Mubende, one of the outbreak's hot spots, according to an update yesterday from the World Health Organization (WHO) Uganda office.
Her illness lifts Uganda's Ebola total to 140 cases and the number of infected health workers to 19, including 7 who died from their infections.
No new deaths were reported, keeping fatalities at 55. The case-fatality rate among the confirmed cases is 39%. Uganda has also reported at least 21 suspected cases, mostly from earlier in the outbreak, all of which were fatal.
Uganda's outbreak began in September and involves the more rare Sudan Ebola strain. Unlike the more common Zaire Ebola strain, there are no approved treatments or vaccines. Officials have said a small number of patients have received experimental treatments, and plans are under way to test as three vaccine candidates.